ENTITY
Medy Tox Inc

Medy Tox Inc (086900 KS)

66
Analysis
Health Care • South Korea
Medy-Tox Inc. is a biopharmaceutical company. The Company researches, develops and manufactures biopharmaceutical products using clostridium botulinum which is a microorganism toxin.
more
Exchange Announcement • 12 Aug 2026 15:00

Report on Business Performance according to Consolidated Financial Statements (Fair Disclosure)

Exchange Announcement • 10 Aug 2026 16:09

Report on Business Performance according to Consolidated Financial Statements (Fair Disclosure)

Exchange Announcement • 02 Jul 2026 10:20

[Revised] Retirement of Stocks

Exchange Announcement • 30 Jun 2026 15:16

[Revised] Retirement of Stocks(ìƒí™˜ì „í™˜ìš°ì„ ì£¼)

Exchange Announcement • 11 Jun 2026 10:51

Decision on Acquisition of Treasury Stock

x